CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 40 enrolled
Drug / intervention
MEDICATION AND EXERCISE TRAININGdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03019796
NCT03019796Early Ph 1Completed
CompareCT.gov

Effects of Exercise Training as a Non-pharmacological Treatment for Metabolic Syndrome and Its Interactions With Subjects Habitual Medications.

University of Castilla-La Mancha·interventional·Posted Jan 13, 2017·Updated Jun 14, 2021

In Brief

A Early Phase 1 clinical trial evaluating MEDICATION AND EXERCISE TRAINING for Exercise Therapy and 2 related conditions. Completed, enrolled 40 participants across 1 site.

Detailed Summary

To analyze the effects of different exercise training modalities (continuous, intervallic, and resistance training) on cardiorespiratory and metabolic fitness of metabolic syndrome patients when this training interacts with their habitual medication.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsExercise Therapy, Metabolic Syndrome X, Cardiorespiratory Fitness
CountriesSpain
CollaboratorsMinisterio de Economía y Competitividad, Spain

Timeline

Early Ph 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 13, 2017
Enrollment StartJul 1, 2015
Primary CompletionApr 1, 2018
Study CompletionAug 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 9.5 years ago

Interventions

MEDICATION AND EXERCISE TRAININGdrug

PARTICIPANTS WILL BE (IN A RANDOMIZED BLINDED FASHION) WITHDRAWN OF THEIR HYPERTENSIVE MEDICATION (I.E., PLACEBO) IN ONE OCCASION AND TESTED WITH THEIR MEDICATION IN ANOTHER, WITH A WEEK WASHOUT PERIOD. THIS TESTING WILL BE REPEATED AFER 4 MONTHS OF EXERCISE TRAINING (48 SESSIONS OF 43 MIN EACH ONE).